JAK1, JAK2, and tyrosine kinase 2(TYK2)are key enzymes implicated in psoriasis, and JAK inhibitors reduce the transcription of pro-inflammatory cytokines by blocking the JAK-STAT pathway (260). The gene discussed is SOAT1; the disease is psoriasis.